DEEP BUCH: Open Payments
NPI 1518113786 · PALOS HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,406 in 77 payments from 12 companies in 2025. Trend: 2023 $968 · 2024 $1,236 · 2025 $1,406
Food & beverage: $1,305Education: $101
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $253 |
| Janssen Pharmaceuticals, Inc | 13 | $212 |
| Axsome Therapeutics, Inc. | 13 | $200 |
| E.R. Squibb & Sons, L.L.C. | 6 | $184 |
| Teva Pharmaceuticals USA, Inc. | 5 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $149 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| Corium, LLC | 6 | $49 |
| ABBVIE INC. | 3 | $46 |
| Indivior Inc. | 1 | $27 |
Products named: INGREZZA, Auvelity, COBENFY, INVEGA SUSTENNA, CAPLYTA, REXULTI, AUSTEDO XR, SPRAVATO.
Industry payments across IL — which companies pay providers there.
